SEC Form 4 · accession 0001180763-26-000005
Foghorn Therapeutics Inc. · FHTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Simba Gill
Director
Period of report
Jun 24, 2026
Accepted (ET)
Jun 25, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001822462
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to buy)F1 | $4.08 | Jun 24, 2026 | A | 28,000 | A | — | Jun 23, 2036 | Common Stock | 28,000 | 28,000 | D |
Explanation of responses
- F1The option vests in full on the first anniversary of the grant date, subject to the reporting person's continued service on the board of directors.